Bodi Envi blog: Guides
Plain, sourced writing on GLP-1 treatment: what the FDA-approved labels and the trials say, what compounded medication is and is not, what things cost, and how to choose a program.
- Guide
Insulin resistance and GLP-1 medications, explained
What insulin resistance is, how it is found, how it links to prediabetes and weight, and what the FDA labels say GLP-1 medications do to insulin.
- Guide
PCOS and GLP-1 medications: what the research shows
What polycystic ovary syndrome has to do with insulin and weight, what studies of GLP-1 medications in PCOS found so far, and what to ask your provider.
- Guide
Hair loss on semaglutide and tirzepatide: what the labels report
How often hair loss was reported in the Wegovy® and Zepbound® trials, why the labels tie it to weight reduction, and what dermatologists say about shedding.
- Guide
Where to inject semaglutide and tirzepatide: sites and rotation
Where the Wegovy® and Zepbound® labels say to inject, how to rotate sites each week, what injection site reactions look like, and what changes with a vial.
- Guide
Tirzepatide dosing: what the label schedule looks like
What the Zepbound® label says about the starting dose, the four week steps, maintenance doses, missed doses and injection days, and who sets your plan.
- Guide
Semaglutide and tirzepatide with B12 or glycine: what the add-ins are
Why some compounded GLP-1 formulations list vitamin B12 or glycine, what each ingredient is, what the approved labels contain, and what has been studied.
- Guide
Not losing weight on semaglutide: what to consider
What the Wegovy® trial measured over 68 weeks, why the first weeks are not the test, the reasons a plateau happens, and what to bring to your provider.
- Guide
Alcohol and semaglutide: what is known
The Wegovy® label has no alcohol section, which warnings still bear on drinking, what a 2026 meta-analysis of trials found, and what to ask a provider.
- Guide
Personalized Compounded semaglutide in California: a buyer's guide
What to verify before ordering personalized compounded semaglutide in California, the role of the state Board of Pharmacy, the FDA's checks and red flags.
- Guide
Semaglutide dosing: what the label schedule looks like
The Wegovy® escalation schedule as the label states it, why the steps exist, how a compounded vial is measured, and the FDA's warning on dosing errors.
- Guide
Storing personalized compounded semaglutide: the label rules
Why the pharmacy label governs, what the Wegovy® label says about temperature, freezing and light, and what the FDA says about warm deliveries.
- Guide
Personalized Compounded semaglutide: the complete guide
What compounded semaglutide is, who may prepare it and under what rules, how prescriptions, measuring and storage work, and what the FDA warns about.
- Guide
Personalized Compounded tirzepatide in Texas: a buyer's guide
What to verify before ordering personalized compounded tirzepatide in Texas, what the Texas State Board of Pharmacy does, and the FDA's checks and red flags.
- Guide
Compounded vs brand name GLP-1: what is actually different
FDA approval, who makes it, pens versus vials, salt forms, the FDA's stated concerns and list prices as of September 2026, side by side.
- Guide
Personalized Compounded tirzepatide vs Zepbound® and Mounjaro®
How compounded tirzepatide differs from Zepbound® and Mounjaro® in approval, oversight, packaging, evidence and price, as the labels and the FDA state it.
- Guide
Your first week on semaglutide: what to expect
What the Wegovy® label says about the starting dose and early effects, how to check and store a compounded vial, and when to message your care team.
- Guide
Semaglutide and tirzepatide compared, in brief
A one table companion to the comparison hub: mechanism, approved uses, label schedules, trial results, side effects and Bodi Envi's prices.
- Guide
Micro dosing GLP-1 medications: what it means and what is known
What people mean by micro dosing semaglutide or tirzepatide, what the labels do and do not describe, and how Bodi Envi's lower dose programs work.
- Guide
GLP-1 medications for weight management: a plain guide
What semaglutide and tirzepatide are, how their FDA-approved labels say they work, what STEP 1 and SURMOUNT-1 found, and what a provider weighs first.
- Guide
How to choose a personalized compounded semaglutide provider
The FDA and LegitScript checks, the questions specific to semaglutide, the red flags to walk away from, and how to read a price.
- Guide
How to choose a personalized compounded tirzepatide provider
The FDA and LegitScript checks, the questions that belong to tirzepatide in particular, the red flags, and how to read a program price.
- Guide
How to choose an online GLP-1 program
How to judge a program rather than a price: the provider model, support after delivery, the price structure and the cancellation terms.
- Guide
How to start with Bodi Envi
The steps Bodi Envi publishes, from the online assessment to provider review, prescription, delivery and care team messaging, with the policies linked.
- Guide
Is personalized compounded semaglutide legal in 2026?
How federal law treats compounding under 503A and 503B as the FDA explains it, what changed when the semaglutide shortage ended, and what the FDA says now.
Start with an online assessment.
Answer a few questions about your health and goals. A licensed provider reviews your answers and decides whether treatment is appropriate for you.
